Archive: 12/04/2017
1st drug for tardive dyskinesia approved
(HealthDay)—Ingrezza (valbenazine), the first drug to treat adults with the neurological disorder tardive dyskinesia, has been approved by the U.S. Food and Drug Administration.
Apr 12, 2017
Report reveals prevalence of sexual assault in nursing homes
A new paper in The Gerontologist examined sexual assault in nursing homes. The report finds that the most vulnerable residents are likely to become victims; legal examinations were infrequent due to administration complexities ...
Apr 12, 2017